(Q54551509)

31 May 2018

title

Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. (English)

1 reference

31 May 2018

author name string

Jörg Gampfer

1

1 reference

31 May 2018

Vojtech Thon

2

1 reference

31 May 2018

Heinz Gulle

3

1 reference

31 May 2018

Hermann M Wolf

4

1 reference

31 May 2018

Martha M Eibl

5

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

31 May 2018

published in

Vaccine

1 reference

31 May 2018

volume

20

1 reference

31 May 2018

issue

9-10

1 reference

31 May 2018

page(s)

1354-1364

1 reference

31 May 2018

Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Interaction of Staphylococcus aureus toxin "superantigens" with human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

The staphylococcal enterotoxins and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Bacterial superantigens--mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Localization of biologically important regions on toxic shock syndrome toxin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Exotoxins of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Superantigen and endotoxin synergize in the induction of lethal shock

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Structure and function of streptococcal and staphylococcal superantigens in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Inhibition of bacterial superantigens by peptides and antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Immunogenicity of Formaldehyde-Inactivated Enterotoxins A and C1 of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Purification and purity assessment of toxic shock syndrome toxin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Nucleotide Sequences and Biologic Properties of Toxic Shock Syndrome Toxin 1 from Ovine- and Bovine-Associated Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

The pH dependence of enterotoxin polymerization by formaldehyde

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Identification of antigenic sites on staphylococcal enterotoxin B and toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Wortmannin inhibits translation of tumor necrosis factor-alpha in superantigen-activated T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

Interleukin-8 production by human monocytic cells in response to staphylococcal exotoxins is direct and independent of interleukin-1 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900470-4

7 January 2021

10.1016/S0264-410X(01)00470-4

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018